Search Results - Chen, Bingliang

Identification of a Gene Signature to Aid Treatment Decisions by Integrated Analysis of Mutated Genes Between Primary and Metastatic Prostate Cancer by Li, Qinyu, Xiao, Xueyan, Chen, Bingliang, Song, Guoda, Zeng, Kai, Miao, Jianping

Get full text Get full text Get full text

A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy by Kuang, Zhihui, Li, Li, Zhang, Pan, Chen, Bingliang, Wu, Min, Ni, Haiqing, Yi, Shuai, Zou, Jia, Liu, Junjian

Get full text Get full text Get full text

Preclinical characterization of Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody for cancer by Zhang, Shuang, Zhang, Min, Wu, Weiwei, Yuan, Zhijun, Tsun, Andy, Wu, Min, Chen, Bingliang, Li, Jia, Miao, Xiaoniu, Miao, Xiaoliang, Liu, Xiaolin, Yu, Dechao, Liu, Junjian

Get full text Get full text Get full text

Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-Analysis by Song, Guoda, Wang, Min, Chen, Bingliang, Long, Gongwei, Li, Hao, Li, Rui, Liu, Zhuo, Wei, Chao, Wang, Tao, Wang, Shaogang, Liu, Jihong, Zhang, Yucong, Liu, Xiaming

Get full text Get full text Get full text

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit by Wang, Jie, Fei, Keke, Jing, Hua, Wu, Zhihai, Wu, Weiwei, Zhou, Shuaixiang, Ni, Haiqing, Chen, Bingliang, Xiong, Yan, Liu, Yanpeng, Peng, Bo, Yu, Dechao, Jiang, Haiping, Liu, Junjian

Get full text Get full text Get full text

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody by Wang, Yan, Pan, Donghui, Huang, Chenrong, Chen, Bingliang, Li, Mingzhu, Zhou, Shuaixiang, Wang, Lizhen, Wu, Min, Wang, Xinyu, Bian, Yicong, Yan, Junjie, Liu, Junjian, Yang, Min, Miao, Liyan

Get full text Get full text Get full text

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity by Jiang, Haiping, Ni, Haiqing, Zhang, Pan, Guo, Xiaoli, Wu, Min, Shen, Haoran, Wang, Jie, Wu, Weiwei, Wu, Zhihai, Ding, Jiazheng, Tang, Rong, Zhou, Shuaixiang, Chen, Bingliang, Yu, Michael, Jing, Hua, Liu, Junjian

Get full text Get full text Get full text

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity by Qiao, Yunqian, Qiu, Yangmin, Ding, Jie, Luo, Nana, Wang, Hao, Ling, Xiaomin, Sun, Jiya, Wu, Zhihai, Wang, Yisen, Liu, Yanpeng, Guo, Feifei, Sun, Ta, Shen, Wanwan, Zhang, Min, Wu, Dongdong, Chen, Bingliang, Xu, Wei, Wang, Xuan

Get full text Get full text Get full text

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity by Liu, Huisi, Wu, Weiwei, Sun, Gangyu, Chia, Tiongsun, Cao, Lei, Liu, Xiaodan, Guan, Jian, Fu, Fenggen, Yao, Ying, Wu, Zhihai, Zhou, Shuaixiang, Wang, Jie, Lu, Jia, Kuang, Zhihui, Wu, Min, He, Luan, Shao, Zhiyuan, Wu, Dongdong, Chen, Bingliang, Xu, Wenqing, Wang, Zhizhi, He, Kaijie

Get full text Get full text Get full text